Poland



Africa: Gilead Under Fire for Not Selling HIV Drug Lenacapavir to MSF

[allAfrica] Pharmaceutical company Gilead Sciences has come under mounting pressure after refusing to sell its breakthrough HIV prevention drug, lenacapavir, directly to Médecins Sans Frontières (MSF), despite repeated requests.
Get more results via ClueGoal